🚀 VC round data is live in beta, check it out!
Arzneiwerk VIDA Valuation Multiples
Discover revenue and EBITDA valuation multiples for Arzneiwerk VIDA and similar public comparables like Exalt, Cyfrowe Centrum Serwisowe, Cambium Networks, Indeco and more.
Arzneiwerk VIDA Overview
About Arzneiwerk VIDA
Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe.
Founded
1983
HQ
Employees
2
Website
Sectors
Financials (FY)
EV
$2M
Arzneiwerk VIDA Financials
Arzneiwerk VIDA reported last fiscal year revenue of $774K and negative EBITDA of ($778K).
In the same fiscal year, Arzneiwerk VIDA generated $774K in gross profit, ($778K) in EBITDA losses, and had net loss of ($983K).
Arzneiwerk VIDA P&L
In the most recent fiscal year, Arzneiwerk VIDA reported revenue of $774K and EBITDA of ($778K).
Arzneiwerk VIDA expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $774K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $774K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 100% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($778K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (101%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (64%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($983K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (127%) | XXX | XXX | XXX |
| Net Debt | — | — | $601K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Arzneiwerk VIDA Stock Performance
Arzneiwerk VIDA has current market cap of $2M, and enterprise value of $2M.
Market Cap Evolution
Arzneiwerk VIDA's stock price is $0.36.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2M | $2M | 0.0% | XXX | XXX | XXX | $-0.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialArzneiwerk VIDA Valuation Multiples
Arzneiwerk VIDA trades at 2.8x EV/Revenue multiple, and (2.7x) EV/EBITDA.
Arzneiwerk VIDA Financial Valuation Multiples
As of April 20, 2026, Arzneiwerk VIDA has market cap of $2M and EV of $2M.
Equity research analysts estimate Arzneiwerk VIDA's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Arzneiwerk VIDA has a P/E ratio of (2.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 2.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (2.7x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (4.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.8x | XXX | XXX | XXX |
| P/E | — | XXX | (2.2x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (1.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Arzneiwerk VIDA Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Arzneiwerk VIDA Margins & Growth Rates
Arzneiwerk VIDA's revenue in the last fiscal year declined by (61%).
Arzneiwerk VIDA's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.6M for the same period.
Arzneiwerk VIDA Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (61%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (101%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (64%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 50% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 164% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Arzneiwerk VIDA Public Comps
See public comps and valuation multiples for other Networking Hardware comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Arzneiwerk VIDA | XXX | XXX | XXX | XXX | XXX | XXX |
| Exalt | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyfrowe Centrum Serwisowe | XXX | XXX | XXX | XXX | XXX | XXX |
| Cambium Networks | XXX | XXX | XXX | XXX | XXX | XXX |
| Indeco | XXX | XXX | XXX | XXX | XXX | XXX |
| Adeunis RF | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Arzneiwerk VIDA M&A Activity
Arzneiwerk VIDA acquired XXX companies to date.
Last acquisition by Arzneiwerk VIDA was on XXXXXXXX, XXXXX. Arzneiwerk VIDA acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Arzneiwerk VIDA
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialArzneiwerk VIDA Investment Activity
Arzneiwerk VIDA invested in XXX companies to date.
Arzneiwerk VIDA made its latest investment on XXXXXXXX, XXXXX. Arzneiwerk VIDA invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Arzneiwerk VIDA
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Arzneiwerk VIDA
| When was Arzneiwerk VIDA founded? | Arzneiwerk VIDA was founded in 1983. |
| Where is Arzneiwerk VIDA headquartered? | Arzneiwerk VIDA is headquartered in Germany. |
| How many employees does Arzneiwerk VIDA have? | As of today, Arzneiwerk VIDA has over 2 employees. |
| Is Arzneiwerk VIDA publicly listed? | Yes, Arzneiwerk VIDA is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Arzneiwerk VIDA? | Arzneiwerk VIDA trades under TLIK ticker. |
| Who are competitors of Arzneiwerk VIDA? | Arzneiwerk VIDA main competitors are Exalt, Cyfrowe Centrum Serwisowe, Cambium Networks, Indeco. |
| What is the current market cap of Arzneiwerk VIDA? | Arzneiwerk VIDA's current market cap is $2M. |
| What is the current revenue of Arzneiwerk VIDA? | Arzneiwerk VIDA's last fiscal year revenue is $774K. |
| What is the current EV/Revenue multiple of Arzneiwerk VIDA? | Current revenue multiple of Arzneiwerk VIDA is 2.8x. |
| Is Arzneiwerk VIDA profitable? | No, Arzneiwerk VIDA is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.